Home › NDC Lookup › RxCUI directory › RxCUI 2055015

Stiripentol 250 MG Powder for Oral Suspension — RxCUI 2055015

RxNorm drug concept · Semantic clinical drug
RxCUI 2055015 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2055015
Official nameStiripentol 250 MG Powder for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)3,030 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Stiripentol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Diacomit is only approved when used together with clobazam — there's no clinical evidence that it works on its own for Dravet syndrome. Part of the reason the combination works wel...
  • Why does my child need to take this medication with clobazam? Can they take it alone?
  • Unfortunately, drowsiness is very common with Diacomit — it happened in about two-thirds of patients in clinical trials. Part of this is because Diacomit raises clobazam levels, an...
  • My child seems very sleepy since starting Diacomit. Is that normal, and what should I do?
📖 Read our full Stiripentol guide →

🕸️ Concept Web — How Stiripentol 250 MG Powder for Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Stiripentol 250 MG Powder for Oral Suspension RxCUI 2055015

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Stiripentol 2054968
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Diacomit 2054974
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Stiripentol Powder for Oral Suspension 2055010
    • Stiripentol Oral Powder Product 2055009
    • Stiripentol Oral Product 2054970
    • Stiripentol Powder for Oral Suspension [Diacomit] 2055012
    • Diacomit Oral Powder Product 2055013
    • Diacomit Oral Product 2054977
    • Powder for Oral Suspension 1540456
    • Oral Powder Product 1294711
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Stiripentol 250 MG SCDC · 2054969
  • Stiripentol Powder for Oral Suspension SCDF · 2055010
  • Stiripentol Oral Powder Product SCDG · 2055009
  • Stiripentol Oral Product SCDG · 2054970

Brand-Name Concepts

  • Stiripentol 250 MG Powder for Oral Suspension [Diacomit] SBD · 2055016
  • Stiripentol 250 MG [Diacomit] SBDC · 2054975
  • Stiripentol Powder for Oral Suspension [Diacomit] SBDF · 2055012
  • Diacomit Oral Powder Product SBDG · 2055013
  • Diacomit Oral Product SBDG · 2054977
  • Diacomit BN · 2054974

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2055015 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68418-7939-06 1 BOTTLE in 1 CARTON (68418-7939-6) / 60 CAPSULE in 1 BOTTL... Diacomit BIOCODEX, INC. 2018-08-21
68418-7940-06 1 BOTTLE in 1 CARTON (68418-7940-6) / 60 CAPSULE in 1 BOTTL... Diacomit BIOCODEX, INC. 2018-08-21
68418-7941-06 60 PACKET in 1 CARTON (68418-7941-6) / 1 POWDER, FOR SUSPEN... Diacomit BIOCODEX, INC. 2018-08-21
68418-7942-06 60 PACKET in 1 CARTON (68418-7942-6) / 1 POWDER, FOR SUSPEN... Diacomit BIOCODEX, INC. 2018-08-21
Observed labelers: BIOCODEX, INC. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.